Garrison Fathman MD
Dr. Fathman is currently developing a novel therapeutic approach to the treatment of autoimmune and allergic diseases by targeting the endogenous regulatory T cell to "turn up" its activity. (read more in the Media Bio)
Dr. Fathman is currently developing a novel therapeutic approach to the treatment of autoimmune and allergic diseases by targeting the endogenous regulatory T cell to "turn up" its activity. (read more in the Media Bio)